Author

Bernard Flourie 1

1 Lyon-Sud Hospital

ACCURACY OF FECAL CALPROTECTIN IN THE ASSESSMENT OF POST-OPERATIVE ENDOSCOPIC RECURRENCE IN PATIENTS WITH CROHN’S DISEASE

Gilles Boschetti, Gildas Phelip, Driffa Moussata, Anne-Laure Charlois, Bernard Flourie, Stéphane Nancey, Anne-Laure Charlois

ACUTE INFUSION REACTIONS UNDER VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS: RESULTS OF A MULTICENTER RETROSPECTIVE OBSERVATIONAL COHORT STUDY

chloé Venturin, Stéphane Nancey, Xavier Roblin, Laurent Peyrin-Biroulet, Nicolas Mathieu, Claire Gay, Pauline Danion, Remi Duclaux-Loras, Camille Meunier, Bernard Flourie, Gilles Boschetti

DIAGNOSTIC AND PROGNOSTIC VALUES OF ANTI-GLYCOPROTEIN 2 ANTIBODIES (GP2A) IN INFLAMMATORY BOWEL DISEASES: RESULTS OF A RETROSPECTIVE MONOCENTRIC COHORT STUDY

Morgane Chavas-Fabre, Anne-Laure Charlois, Nicole Fabien, Claire Gay, Pauline Danion, Camille Meunier, Remi Duclaux-Loras, Mathias Faure, Bernard Flourie, Stéphane Nancey, Gilles Boschetti

EARLY DETECTION OF ANTI-DRUG-ANTIBODIES USING DRUG-TOLERANT ASSAY WITHIN THE INDUCTION PHASE AT WEEK 2 PREDICTS THE LOSS OF CLINICAL RESPONSE TO ANTI-TNF IN INFLAMMATORY BOWEL DISEASE PATIENTS

Quentin Tournier, Stéphane Paul, Nicolas Williet, Anne Emmanuelle Berger, Pauline Veyrard, Gilles Boschetti, J. Marc Phelip, Bernard Flourie, Stéphane Nancey, Xavier Roblin

EFFECTIVENESS AND SAFETY OF USTEKINUMAB 90 MG EVERY FOUR WEEKS IN CROHN'S DISEASE

Mathurin Fumery, Laurent Peyrin-Biroulet, Stéphane Nancey, Pauline Veyrard, Guillaume Bouguen, Romain Altwegg, Stéphanie Viennot, David Laharie, Jerome Filippi, Anthony Buisson, Anne BOZON, Franck Brazier, Lieven Pouillon, Bernard Flourie, Laurent Siproudhis, Lucile Boivineau, Xavier Roblin, Xavier Treton

EFFICACY AND SAFETY OF GOLIMUMAB IN CROHN’S DISEASE : A FRENCH NATIONAL RETROSPECTIVE STUDY

Chloé Martineau, Bernard Flourie, Pauline Wils, Thibaut Vaysse, Romain Altwegg, Anthony Buisson, Aurelien Amiot, Guillaume Pineton de Chambrun, Vered Abitbol, Mathurin Fumery, Xavier Hebuterne, Stéphanie Viennot, David Laharie, Laurent Beaugerie, Stéphane Nancey, Harry Sokol

ENRICHMENT OF CIRCULATING DOUBLE POSITIVE INTERLEUKIN-17 PRODUCING FOXP3+ CD4+ T CELL SUBSETS ARE ASSOCIATED WITH A HIGHER RISK OF FURTHER RELAPSE IN CROHN’S DISEASE IN REMISSION: AN OBSERVATIONAL, PROSPECTIVE MULTICENTER STUDY

Gilles Boschetti, Bernard Flourie, Xavier Roblin, Stéphane Paul, Jacques Bienvenu, Gilles Bommelaer, Anthony Buisson, Emilie Del Tedesco, Cendrine Josson, Stéphane Legastelois, Stéphane Nancey

HEAD-TO-HEAD COMPARISON OF 5 FECAL MARKERS TO PREDICT RESPONSE TO INDUCTION AND MAINTENANCE THERAPY WITH INFLIXIMAB IN ULCERATIVE COLITIS PATIENTS; A PROSPECTIVE STUDY.

Anne Frin, Stéphane Nancey, Jerome Filippi, Gilles Boschetti, Bernard Flourie, Jocelyne Drai, Patricia Ferrari, Xavier Hebuterne

IBD-INFO QUESTIONNAIRE: A MULTICENTER FRENCH UP-TO-DATE SURVEY OF PATIENT KNOWLEDGE IN INFLAMMATORY BOWEL DISEASE

Pauline Danion, Anthony Buisson, Xavier Roblin, Nicolas Mathieu, Anne-Laure Charlois, Nicolas Williet, Emilie Del Tedesco, Bernard Flourie, Stéphane Nancey, Gilles Boschetti

INTEREST IN THE ADDITION OF AZATHIOPRINE (AZA) TO THE SWITCH OF ANTI-TNF IN IBD PATIENTS IN CLINICAL RELAPSE WITH UNDETECTABLE ANTI-TNF TROUGH LEVELS AND ANTI-DRUG ANTIBODIES: A PROSPECTIVE RANDOMIZED TRIAL

Xavier Roblin, Stéphane Paul, Gilles Boschetti, Jean Marc Phelip, Emilie Del Tedesco, Stéphane Nancey, Nicolas Williet, Bernard Flourie

Item 1 - 10 / 33
1
2 3 4